London-based SAVA raises over €7.4 million to build preventative, personalised, precision health monitoring at scale

UK startup Sava raises $8m to develop next-gen continuous glucose monitor

SAVA's health monitoring microsensor raises $8M in Seed funding

Sava Raises $8M in Seed Funding

London-based SAVA snaps $8M to build health monitoring microsensors — TFN

SAVA, a UK-based startup developing a real-time, affordable, and painless microsensor for health monitoring, has raised over €7.4 million in a Seed funding round led by Balderton Capital and Exor Ventures. The company's first microsensor focuses on glucose monitoring for people with diabetes, aiming to revolutionize healthcare by making world-leading monitoring technology accessible to all. The funding will be used to expand SAVA's team, design its next-generation product line, and demonstrate the platform's clinical performance.

SAVA Raises €7.4 Million to Revolutionize Health Monitoring with Microsensor Technology

SAVA is a UK-based startup developing a real-time, affordable, and painless microsensor for health monitoring. Their smart, connected wearable patch detects molecules in the interstitial fluid, just under the skin, and delivers data directly to a user's phone. SAVA's first microsensor focuses on glucose monitoring for people with diabetes, aiming to revolutionize healthcare by making world-leading monitoring technology accessible to all. The company's modular design allows for future expansion to monitor multiple molecules, enabling applications in chronic conditions, drug adherence, personalized therapy, and more.

SAVA is a UK-based startup developing a real-time, affordable, and painless microsensor for health monitoring.

a year ago

SAVA Raises €7.4 Million to Revolutionize Health Monitoring with Microsensor Technology

ProblemHealthcare

Solution

Covered on